Literature DB >> 34396558

Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions.

Joshua D Brown1,2,3, Kevin J Rivera Rivera4, Leilanie Y Crespo Hernandez4, Matthew R Doenges4, India Auchey4, Thanh Pham4, Amie J Goodin1,2,3.   

Abstract

The purpose of this narrative review is to describe the current use environment of both natural and synthetic cannabinoids while providing context for cannabinoid chemistry and pharmacology. In addition to a long history of recreational and nonmedical use, natural cannabinoids are increasingly used as prescription products, through medical cannabis programs, and as consumer health products. Despite anecdotal safety evidence, cannabis and cannabinoids are pharmacologically complex and pose risks for adverse drug events and drug-drug interactions. Synthetic cannabinoids, particularly agonists of cannabinoid receptors, are more potent than natural cannabinoids and can lead to more severe reactions and medical emergencies. This review provides a summary of approved uses and an overview of mechanisms of action for adverse drug events with natural and synthetic cannabinoids. Clinical considerations for special populations that may be at heightened risk for drug-drug interactions and adverse drug events while using natural or synthetic cannabinoids are examined, and recommendations are provided.
© 2021, The American College of Clinical Pharmacology.

Entities:  

Keywords:  adverse drug events; cannabinoid pharmacology; cannabinoids; drug-drug interactions; synthetic cannabinoids

Mesh:

Substances:

Year:  2021        PMID: 34396558     DOI: 10.1002/jcph.1871

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  2 in total

1.  Endocannabinoid-Binding Receptors as Drug Targets.

Authors:  María Gómez-Cañas; Carmen Rodríguez-Cueto; Valentina Satta; Inés Hernández-Fisac; Elisa Navarro; Javier Fernández-Ruiz
Journal:  Methods Mol Biol       Date:  2023

2.  Will Cannabis or Cannabinoids Protect You from SARS-CoV-2 Infection or Treat COVID-19?

Authors:  Joshua D Brown; Amie J Goodin
Journal:  Med Cannabis Cannabinoids       Date:  2022-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.